MoneyWorks4Me

Sresta Natural Bioproducts Ltd

Share Analysis – Quality, Valuation Zone, Price Trend & DeciZen Rating BSE: 0 NSE: Agriculture | Small Cap | Sresta Natural Bio. Share Price

BSE Share Price
Not Listed

Sresta Natural Bioproducts Ltd

Share Analysis – Quality, Valuation Zone, Price Trend & DeciZen Rating BSE: 0 NSE: Agriculture | Small Cap | Sresta Natural Bio. Share Price

BSE Share Price
Not Listed
Key Metrics
Valuation Multiples
Market Cap
₹0 Cr.
Current Price
₹0
52-Week Low / High
₹0 / 0
TTM EPS
₹0
TTM Sales
₹0 Cr.
Book Value per Share
₹10
P/E Ratio
0.00
Industry PE
15.5
Price to Book (P/B)
0.00
Price to Sales (P/S)
0.00
EV/EBITDA
0.00
Dividend Yield
NAN%
Profitability Efficiency
Return on Equity (ROE)
14.58%
Return on Capital Employed (ROCE)
17.23%
Return on Assets (ROA)
6.08%
Operating Profit Margin
8.4%
Net Profit Margin
3.33%
Gross Profit Margin
6.5%
Growth Momentum
1-yr vs 3-yr growth
Sales Growth (1 Year)
Improving versus 3-year growth rate
4.23%
Operating Profit Growth (1 Year)
Slowing versus 3-year growth rate
5.11%
Net Profit Growth (1 Year)
-
9.83%
Asset Quality
Promoter Holding
%
Pledged shares (%) of Promoter's holding (%)
%
Reserves
-
Equity
₹18.8 Cr.
Face Value
₹10
All Time Low / High
- / -

10 Year X-Ray :

Analysis of Financial Track Record (Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end)

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end.

Financial track record gives insight into the company's performance on key parameters over the past ten years. MoneyWorks4me’s proprietary colour codes make it easy for retail investors to gauge the company’s past performance.

Value Creation ⓘ

Mar'10Mar'11Mar'12Mar'13Mar'14Mar'15Mar'16Mar'17Mar'18Mar'19TTM
ROCE % ⓘ-27.8%3.5%0.9%0.9%0.4%3.3%4.1%-7.5%-1.9%2.5%-
Value Creation
Index ⓘ
-3.0-0.8-0.9-0.9-1.0-0.8-0.7-1.5-1.1-0.8-

Growth Parameters ⓘ

Sales ⓘ10.116.129.74779.6111156169169176176
Sales YoY Gr.-59.3%84.3%58.4%69.6%39.8%40.6%7.8%0.1%4.2%-
Adj EPS ⓘ-6.50.100.20.20.2-0.7-5.9-4.2-1.4-0.7
YoY Gr.-NA-88.9%1500%0%37.5%-418.2%NANANA-
BVPS (₹) ⓘ62124.427.933.447.459.454.950.948.847.8
Adj Net
Profit ⓘ
-1.7000.20.20.3-1-10.3-7.3-2.6-1
Cash Flow from Ops. ⓘ00000-19.5-24.1-7.910.70.9-
Debt/CF from Ops. ⓘ00000-0.9-1.5-4.4342.5-

CAGR ⓘ

9 Years 5 Years 3 Years 1 Years
Sales ⓘ37.4%17.2%4%4.2%
Adj EPS ⓘNA-254.8%NANA
BVPSⓘ26.3%7.9%-6.4%-4.1%
Share Price - - - -

Key Financial Parameters ⓘ

Mar'10Mar'11Mar'12Mar'13Mar'14Mar'15Mar'16Mar'17Mar'18Mar'19TTM
Return on
Equity % ⓘ
-34.40.300.60.50.5-1.3-10.9-7.8-2.9-1.4
Op. Profit
Mgn % ⓘ
-22.71.10.60.60.35.46.2-55.38.6NAN
Net Profit
Mgn % ⓘ
-16.80.100.40.30.3-0.7-6.1-4.3-1.5-0.7
Debt to
Equity ⓘ
1.10.30.10.10.30.30.40.40.40.4-
Working Cap
Days ⓘ
1491662042172032452542652632610
Cash Conv.
Cycle ⓘ
130144510845-1,0411281351611311120

Valuation of Sresta Natural Bio. - Consolidated

YTD 1Y 3Y 5Y 10Y Max
mw4me loader

YTD 1Y 3Y 5Y 10Y Max
mw4me loader

YTD 1Y 3Y 5Y 10Y Max
mw4me loader

YTD 1Y 3Y 5Y 10Y Max
mw4me loader

mw4me loader

Analyst's Notes

data not found
No data found!

Management X-Ray

Shareholding Pattern

No Data To Display

Promoter's Holding & Share Pledging

Financials

PARTICULARSMar'16Mar'17Mar'18Mar'19Mar'20Mar'21
Sales185.19210.28205.18223.28262.28312.07
Operating Expenses ⓘ + 177.06217.46194.75204.25238.58287.16
Manufacturing Costs17.3419.87000.751.34
Material Costs106.37116.45107.26108.50164.60199.04
Employee Cost 13.1917.2917.9018.8732.5234.20
Other Costs ⓘ 40.1663.8469.5976.8840.7152.59
Operating Profit ⓘ 8.13-7.1810.4319.0323.7024.91
Operating Profit Margin (%) 4.4%-3.4%5.1%8.5%9.0%8.0%
Other Income ⓘ + 3.471.211.572.694.152.30
Exceptional Items ⓘ 000000
Interest ⓘ 4.457.536.886.327.526.94
Depreciation ⓘ 8.861.5813.1214.976.256.53
Profit Before Tax ⓘ -1.71-15.08-7.990.4314.0813.74
Tax ⓘ 1.46-3.60-0.7204.623.35
Profit After Tax -3.18-11.49-7.270.439.4610.39
PAT Margin (%) -1.7%-5.5%-3.5%0.2%3.6%3.3%
Adjusted EPS (₹)-2.2-6.6-4.20.25.25.7
Dividend Payout Ratio (%)0%0%0%0%0%0%
PARTICULARSMar'16Mar'17Mar'18Mar'19Mar'20Mar'21

Equity and Liabilities

Shareholders Fund + 86.3590.9183.2982.2466.4876.09
Share Capital ⓘ 19.2918.7818.8118.2518.2618.26
Reserves ⓘ 67.0672.1364.486448.2257.83
Debt +55.0245.2740.1641.7144.5552.62
Long Term Debt5.5416.3715.9612.377.6311.29
Short Term Debt49.4828.9024.2029.3436.9241.33
Minority Interest000000
Trade Payables15.8712.0127.2429.8735.1538.45
Others Liabilities ⓘ 5.126.488.389.8811.6416.66
Total Liabilities ⓘ 162.36154.67159.08163.71157.81183.83

Fixed Assets

Net Fixed Assets ⓘ +17.7318.5217.8316.9528.3030.60
Gross Block21.1223.5324.4424.6740.7048.66
Accumulated Depreciation3.395.016.607.7212.3918.06
CWIP ⓘ 000000
Investments ⓘ 0.190.190000
Inventories70.0159.3557.2564.4066.82106.28
Trade Receivables34.4336.3139.0232.8343.2431.25
Cash Equivalents 5.556.707.7110.2710.709.07
Others Assets ⓘ 34.4533.6037.2639.268.756.63
Total Assets ⓘ 162.36154.67159.08163.71157.81183.83
PARTICULARSMar'16Mar'17Mar'18Mar'19Mar'20Mar'21
Cash Flow From Operating Activity ⓘ + 0-2.9313.878.5516.492.05
PBT ⓘ 0-15.08-7.990.4314.0813.74
Adjustment ⓘ 03.465.878.2814.3015.84
Changes in Working Capital ⓘ 08.6915.270.27-11.61-25.28
Tax Paid ⓘ 0000-0.28-2.25
Cash Flow From Investing Activity ⓘ + 0-2.91-0.91-0.890.59-0.13
Capex 0-2.39-0.91-0.89-1.26-2.56
Net Investments 00001.362.07
Others ⓘ 0-0.51000.480.36
Cash Flow From Financing Activity ⓘ + 06.98-11.95-5.10-15.28-1.48
Net Proceeds from Shares ⓘ 00.110.030.020.010.01
Net Proceeds from Borrowing ⓘ 0000-0.58-4.30
Interest Paid ⓘ 0-7.07-6.88-6.32-5.80-4.67
Dividend Paid ⓘ 000000
Others ⓘ 013.94-5.101.20-8.917.49
Net Cash Flow ⓘ 01.141.012.561.790.44
PARTICULARSMar'16Mar'17Mar'18Mar'19Mar'20Mar'21
Ratios
ROE (%)-4.82-14.78-9.650.6914.4914.58
ROCE (%)2.18-5.65-0.896.0819.2717.23
Asset Turnover Ratio1.141.331.311.381.631.83
PAT to CFO Conversion(x)N/AN/AN/A19.881.740.2
Working Capital Days
Receivable Days67.9061.406758.7052.9043.60
Inventory Days138112.30103.7099.4091.30101.20
Payable Days54.5043.7066.8096.1072.1067.50

Top 5 Mutual Funds Holding

Last Visited Stocks

Announcements

Sresta Natural Bioproducts Ltd FAQs

The current trading price of Sresta Natural Bio. on 01-Jan-1970 05:30 is ₹0.00.

Market capitalization or market cap is determined by multiplying the current market price of a company's shares with the total number of shares outstanding. As of 31-Dec-1969 the market cap of Sresta Natural Bio. stood at ₹0.00 Cr

The latest P/E ratio of Sresta Natural Bio. as of 31-Dec-1969 is 0.00.

The latest P/B ratio of Sresta Natural Bio. as of 31-Dec-1969 is 0.00.

The 52-week high of Sresta Natural Bio. is ₹0.00 and the 52-week low is ₹0.00.

The TTM revenue is Trailing Twelve Months sales. The TTM revenue/sales of Sresta Natural Bio. is ₹176 ( Cr.) .

Data is not available for this company.

No data found

No data found

About Sresta Natural Bioproducts Ltd

No data to display
You have 36 views remaining as a Guest User. To get DeciZen Rating of 3,500+ Stocks based on their Quality, Valuation and Price Trend Login Now